Suplatast tosilate, a novel anti-allergic drug, in asthmatic patients receiving high-dose inhaled corticosteroids

被引：0
|
作者：
Tamaoki, J
Kondo, M
Tagaya, E
Nagano, Y
Nagal, A
Kawagoe, M
Hanyu, F
机构：
[1] Hamacho Ctr Build Clin, Tokyo, Japan
[2] Tokyo Womens Univ, Dept Med 1, Sch Med, Tokyo, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 1999年 / 159卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：A625 / A625
页数：1
相关论文
共 50 条
  • [31] GUT PROTECTION BY CYCLOPHOSPHAMIDE PRIMING IN PATIENTS RECEIVING HIGH-DOSE MELPHALAN - EFFECT OF DRUG SCHEDULING
    MANSI, J
    ELLIS, E
    VINER, C
    MUNDY, J
    SMITH, T
    MILLAR, J
    MILAN, S
    GORE, M
    CUNNINGHAM, D
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (02) : 149 - 151
  • [32] Unexpectedly low drug exposures among Ugandan patients with TB and HIV receiving high-dose rifampicin
    Kengo, Allan
    Gausi, Kamunkhwala
    Nabisere, Ruth
    Musaazi, Joseph
    Buzibye, Allan
    Omali, Denis
    Aarnoutse, Rob
    Lamorde, Mohammed
    Dooley, Kelly E.
    Sloan, Derek James
    Sekaggya-Wiltshire, Christine
    Denti, Paolo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (11)
  • [33] Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function
    Lee, DKC
    Bates, CE
    Currie, GP
    Cowan, LA
    McFarlane, LC
    Lipworth, BJ
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2004, 93 (03) : 253 - 258
  • [34] Implementation and Outcomes of an Empiric Ivermectin Strongyloides Treatment Protocol for Patients Receiving High-Dose Corticosteroids for Severe COVID-19
    Swart, Benjamin
    Ahiskali, Aileen
    Wolf, Jack M.
    Shaughnessy, Megan
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2023, 109 (03): : 650 - 655
  • [35] IMPACT OF OMALIZUMAB ON EMERGENCY-DEPARTMENT VISITS, HOSPITALIZATIONS AND CORTICOSTEROID USE IN PATIENTS WITH UNCONTROLLED ASTHMA USING HIGH-DOSE INHALED CORTICOSTEROIDS
    Lafeuille, M. H.
    Dean, J.
    Zhang, J.
    Duh, M. S.
    Gorsh, B.
    Lefebvre, P.
    VALUE IN HEALTH, 2012, 15 (04) : A52 - A52
  • [36] Impact of Omalizumab on Emergency-Department Visits, Hospitalizations and Corticosteroid Use in Patients with Uncontrolled Asthma Using High-Dose Inhaled Corticosteroids
    Lafeuille, M.
    Dean, J.
    Zhang, J.
    Duh, M. S.
    Gorsh, B.
    Lefebvre, P.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB73 - AB73
  • [37] Relationship of adverse events to serum drug levels in patients receiving high-dose azithromycin for mycobacterial lung disease
    Brown, BA
    Griffith, DE
    Girard, W
    Levin, J
    Wallace, RJ
    CLINICAL INFECTIOUS DISEASES, 1997, 24 (05) : 958 - 964
  • [38] Cough Response to High-Dose Inhaled Corticosteroids in Patients with Chronic Cough and Fractional Exhaled Nitric Oxide Levels ≥ 25 ppb: A Prospective Study
    Lee, Ji-Ho
    Kang, Sung-Yoon
    Yu, Iseul
    Park, Kyung Eun
    Oh, Ji-Yoon
    Lee, Ji-Hyang
    Park, So-Young
    Kim, Min-Hye
    Jo, Eun-Jung
    Moon, Ji-Yong
    Kim, Sae-Hoon
    Kim, Sang-Hoon
    Lee, Byung-Jae
    Song, Woo-Jung
    LUNG, 2024, 202 (03) : 275 - 280
  • [39] BASELINE CHARACTERISTICS OF PATIENTS ON MEDIUM- VS HIGH-DOSE INHALED CORTICOSTEROIDS IN PATIENTS INITIATING DUPILUMAB IN A REAL-WORLD CLINICAL SETTING: THE RAPID REGISTRY
    Lugogo, Njira L.
    Cote, Andreanne
    Bourdin, Arnaud
    Peters, Anju T.
    Bacharier, Leonard B.
    Xia, Changming
    Pandit-Abid, Nami
    Jacob-Nara, Juby A.
    Sacks, Harry
    Rowe, Paul J.
    Deniz, Yamo
    Soliman, Mena
    CHEST, 2024, 166 (04) : 4721A - 4724A
  • [40] Inflammatory Biomarkers Demonstrate Predictive Capacity for Mortality in COVID-19-Related ARDS Patients Receiving High-Dose Corticosteroids: A Longitudinal Analysis
    Daenen, Katrijn
    Boyd, Anders
    Huijben, Jilske A.
    Stoof, Sara C. M.
    Bos, Lieuwe D. J.
    Gommers, Diederik
    van Gorp, Eric C. M.
    Dalm, Virgil A. S. H.
    Endeman, Henrik
    JOURNAL OF INFLAMMATION RESEARCH, 2025, 18 : 2395 - 2408
12345